400-998-5282
专注多肽 服务科研

Liraglutide 是一种胰高血糖素样肽-1 (GLP-1) 受体激动剂,用于研究 2 型糖尿病。
编号:637469
CAS号:204656-20-2
单字母:H2N-HAEGTFTSDVSSYLEGQAA-K(gamaGlu_palmitoyl)-EFIAWLVRGRG-OH
Liraglutide 是一种胰高血糖素样肽-1 (GLP-1) 受体激动剂,用于研究 2 型糖尿病。
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
Liraglutide (Synonyms: 利拉鲁肽) 中文名:利拉鲁肽 Liraglutide 是一种胰高血糖素样肽-1 (GLP-1) 受体激动剂,用于研究 2 型糖尿病。 体外研究:Liraglutide binds to the same receptors as does the endogenous metabolic hormone GLP-1. Liraglutide is an injectable drug for the treatment of type 2 diabetes, also can be used to treat obesity in adults with some related comorbidity. Liraglutide activated AMPK/SREBP1 pathway in oxLDL-stimulated Raw264.7 cells。





